SEC ownership of Imunon, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000749647.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

21/37

Latest evidence

05 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 2 signals
Latest 13D/G holder
ARMISTICE CAPITAL, LLC
Latest parsed ownership date
05 Jun 2026
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000749647
Issuer location
Lawrenceville, NJ

Ownership snapshot

Top shareholders of Imunon, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
21/37
Latest evidence
05 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 10% 16 rows are not safely comparable across share classes. 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-8 of 37 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 10%.

21 of 37 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership Top 5
ARMISTICE CAPITAL, LLC 10%
INTRACOASTAL CAPITAL, LLC 5%
Ayrton Capital LLC 0.05%
Jeffrey Wayne Church 0%
VANGUARD CAPITAL MANAGEMENT LLC 1.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 37 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13F 13D/G
Company
10%
from 13D/G
$1,024,090
348,330 shares
31 Mar 2026
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
5%
$650,990
1,067,196 shares
-$26,789 30 Jun 2025
Ayrton Capital LLC
13D/G
0.05%
$1,220
2,000 shares
-$761,280 30 Jun 2025
Jeffrey Wayne Church
3/4/5
CFO
0%
$104
26 shares
15 Jan 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
1.4%
$141,285
48,056 shares
31 Mar 2026
Riverview Capital Advisers, LLC
13F
Company
13F
0.98%
$247,765
34,364 shares
31 Mar 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.95%
$97,644
33,211 shares
31 Mar 2026
VANGUARD FIDUCIARY TRUST CO
13F
Company
13F
0.38%
$39,011
13,269 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 10 Jun 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-18 of 18 reporting-owner rows connected to Imunon, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
18
Largest Forms 3/4/5 holder
Michael H. Tardugno
Net 12M change
$0
Latest report
05 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Michael H. Tardugno Executive Chairman of Board, Director $64,919 Median 05 Jun 2026
James E. Dentzer Director $43,991 Median 22 May 2026
Frederick J. Fritz Director $41,445 Median 22 May 2026
Kimberly Bragg Cfo $40,596 Mixed 02 Jan 2026
Donald P. Braun Director $27,397 Median 22 May 2026
Christine A. Pellizzari Director $23,937 Median 22 May 2026
Sebastien Hazard Chief Medical Officer $19,600 Mixed 07 Dec 2023
Stacy Lindborg President and CEO, Director $17,677 Median 05 Jun 2026
Jeffrey Wayne Church Cfo $104 Mixed 15 Jan 2026
Timothy J. Tumminello Controller Mixed 13 Jun 2022
Robert W. Hooper Director Mixed 13 Jun 2022
Cao Constantine J. Kardaras Chief Accounting Officer Mixed 13 Jun 2022
Corinne le Goff President and CEO, Director Mixed 17 Mar 2023
David G. Gaiero Chief Financial Officer Mixed 01 Jun 2024
Douglas V Faller Chief Medical Officer Mixed 02 Jan 2026
Khursheed Anwer Chief Scientific Officer Mixed 02 Jan 2026
Pok Yu Augustine Chow Director Mixed 17 Mar 2023
Susan Eylward General Counsel and Corp Sec Mixed 02 Jan 2026

Recent insider transactions for Imunon, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Michael H. Tardugno IMNN Common Stock Award 46.7% 4,089 12,838 05 Jun 2026 Direct
Stacy Lindborg IMNN Common Stock Award 43.7% 1,593 5,235 05 Jun 2026 Direct
Michael H. Tardugno IMNN Common Stock Award 66.2% 3,484 8,749 22 May 2026 Direct
Christine A. Pellizzari IMNN Common Stock Award 215% 5,557 8,142 22 May 2026 Direct
James E. Dentzer IMNN Common Stock Award 292.2% 11,148 14,963 22 May 2026 Direct
Donald P. Braun IMNN Common Stock Award 116.3% 5,011 9,319 22 May 2026 Direct
Frederick J. Fritz IMNN Common Stock Award 274.2% 10,330 14,097 22 May 2026 Direct
Stacy Lindborg IMNN Common Stock Award 69.3% 1,491 3,642 22 May 2026 Direct
Kimberly Bragg IMNN Stock Option (Right to Buy) Award 9,050 9,050 02 Jan 2026 Direct
Khursheed Anwer IMNN Stock Option (Right to Buy) Award 15,736 15,736 02 Jan 2026 Direct
Frederick J. Fritz IMNN Stock Option (Right to Buy) Award 5,892 5,892 02 Jan 2026 Direct
Douglas V Faller IMNN Stock Option (Right to Buy) Award 12,667 12,667 02 Jan 2026 Direct
Susan Eylward IMNN Stock Option (Right to Buy) Award 8,251 8,251 02 Jan 2026 Direct
Christine A. Pellizzari IMNN Stock Option (Right to Buy) Award 4,827 4,827 02 Jan 2026 Direct
Donald P. Braun IMNN Stock Option (Right to Buy) Award 5,881 5,881 02 Jan 2026 Direct
James E. Dentzer IMNN Stock Option (Right to Buy) Award 4,405 4,405 02 Jan 2026 Direct
Michael H. Tardugno IMNN Stock Option (Right to Buy) Award 43,821 43,821 02 Jan 2026 Direct
Stacy Lindborg IMNN Stock Option (Right to Buy) Award 56,187 56,187 02 Jan 2026 Direct
Stacy Lindborg IMNN Common Stock Options Exercise 87% 1,667 3,584 06 Sep 2025 Direct
Stacy Lindborg IMNN Restricted Stock Options Exercise -100% -1,667 0 06 Sep 2025 Direct
James E. Dentzer IMNN Common Stock Award 3,318 3,318 04 Aug 2025 Direct
James E. Dentzer IMNN Stock Option (Right to Buy) Award 250 250 04 Aug 2025 Direct
Christine A. Pellizzari IMNN Common Stock Award 2,248 2,248 04 Aug 2025 Direct
Christine A. Pellizzari IMNN Stock Option (Right to Buy) Award 250 250 04 Aug 2025 Direct
Donald P. Braun IMNN Common Stock Award 119.5% 2,040 3,747 04 Aug 2025 Direct
Donald P. Braun IMNN Stock Option (Right to Buy) Award 250 250 04 Aug 2025 Direct
Frederick J. Fritz IMNN Common Stock Award 402.7% 3,161 3,946 04 Aug 2025 Direct
Frederick J. Fritz IMNN Stock Option (Right to Buy) Award 250 250 04 Aug 2025 Direct
Khursheed Anwer IMNN Stock Option (Right to Buy) Award 1,667 1,667 04 Aug 2025 Direct
Kimberly Bragg IMNN Stock Option (Right to Buy) Award 667 667 04 Aug 2025 Direct
Susan Eylward IMNN Stock Option (Right to Buy) Award 417 417 04 Aug 2025 Direct
Michael H. Tardugno IMNN Stock Option (Right to Buy) Award 1,667 1,667 04 Aug 2025 Direct
Stacy Lindborg IMNN Stock Option (Right to Buy) Award 5,000 5,000 04 Aug 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .